MinnesotaPsilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Apr 22Author added RymerLatest
- Mar 16Committee report, to adopt as amended and re-refer to Commerce Finance and PolicyMinor
- Mar 12Authors added Repinski and Lee, X.
- Feb 25Author added West as second author
- 2025
- Apr 1Author added Sencer-Mura
- Mar 27Introduction and first reading, referred to Health Finance and PolicyIntroduced